 | • レポートコード：QYR2104Z4498 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ペプチドベース心血管治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビバリルジン、エプチフィバチド、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペプチドベース心血管治療薬の市場動向 ・企業の競争状況、市場シェア ・ペプチドベース心血管治療薬の種類別市場規模（ビバリルジン、エプチフィバチド、その他） ・ペプチドベース心血管治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・ペプチドベース心血管治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ペプチドベース心血管治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチドベース心血管治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチドベース心血管治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチドベース心血管治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Novartis、Ipsen、Merck、Mylan、Fresenius、Apotex Holdings、Novetide、Amneal Pharmaceuticals、Dr. Reddy's Laboratories） ・結論 |
Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.
Market Analysis and Insights: Global Peptide Based Cardiovascular Therapeutics Market
The global Peptide Based Cardiovascular Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Based Cardiovascular Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Based Cardiovascular Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Based Cardiovascular Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Based Cardiovascular Therapeutics market.
Global Peptide Based Cardiovascular Therapeutics Scope and Market Size
Peptide Based Cardiovascular Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Cardiovascular Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Bivalirudin
Eptifibatide
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
AstraZeneca
Novartis
Ipsen
Merck
Mylan
Fresenius
Apotex Holdings
Novetide
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Cardiovascular Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bivalirudin
1.2.3 Eptifibatide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide Based Cardiovascular Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Cardiovascular Therapeutics Market Perspective (2016-2027)
2.2 Peptide Based Cardiovascular Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Cardiovascular Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Based Cardiovascular Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Based Cardiovascular Therapeutics Industry Dynamic
2.3.1 Peptide Based Cardiovascular Therapeutics Market Trends
2.3.2 Peptide Based Cardiovascular Therapeutics Market Drivers
2.3.3 Peptide Based Cardiovascular Therapeutics Market Challenges
2.3.4 Peptide Based Cardiovascular Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Cardiovascular Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Cardiovascular Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Based Cardiovascular Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Based Cardiovascular Therapeutics Revenue
3.4 Global Peptide Based Cardiovascular Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Cardiovascular Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Cardiovascular Therapeutics Revenue in 2020
3.5 Peptide Based Cardiovascular Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Based Cardiovascular Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Based Cardiovascular Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Based Cardiovascular Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Cardiovascular Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Type (2022-2027)
5 Peptide Based Cardiovascular Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Cardiovascular Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peptide Based Cardiovascular Therapeutics Market Size (2016-2027)
6.2 North America Peptide Based Cardiovascular Therapeutics Market Size by Type
6.2.1 North America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2027)
6.3 North America Peptide Based Cardiovascular Therapeutics Market Size by Application
6.3.1 North America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2027)
6.4 North America Peptide Based Cardiovascular Therapeutics Market Size by Country
6.4.1 North America Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Peptide Based Cardiovascular Therapeutics Market Size (2016-2027)
7.2 Europe Peptide Based Cardiovascular Therapeutics Market Size by Type
7.2.1 Europe Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2027)
7.3 Europe Peptide Based Cardiovascular Therapeutics Market Size by Application
7.3.1 Europe Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2027)
7.4 Europe Peptide Based Cardiovascular Therapeutics Market Size by Country
7.4.1 Europe Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide Based Cardiovascular Therapeutics Market Size (2016-2027)
9.2 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type
9.2.1 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application
9.3.1 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Country
9.4.1 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peptide Based Cardiovascular Therapeutics Introduction
11.1.4 Pfizer Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Peptide Based Cardiovascular Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Peptide Based Cardiovascular Therapeutics Introduction
11.3.4 Novartis Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Ipsen
11.4.1 Ipsen Company Details
11.4.2 Ipsen Business Overview
11.4.3 Ipsen Peptide Based Cardiovascular Therapeutics Introduction
11.4.4 Ipsen Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.4.5 Ipsen Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Peptide Based Cardiovascular Therapeutics Introduction
11.5.4 Merck Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Peptide Based Cardiovascular Therapeutics Introduction
11.6.4 Mylan Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Fresenius
11.7.1 Fresenius Company Details
11.7.2 Fresenius Business Overview
11.7.3 Fresenius Peptide Based Cardiovascular Therapeutics Introduction
11.7.4 Fresenius Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.7.5 Fresenius Recent Development
11.8 Apotex Holdings
11.8.1 Apotex Holdings Company Details
11.8.2 Apotex Holdings Business Overview
11.8.3 Apotex Holdings Peptide Based Cardiovascular Therapeutics Introduction
11.8.4 Apotex Holdings Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.8.5 Apotex Holdings Recent Development
11.9 Novetide
11.9.1 Novetide Company Details
11.9.2 Novetide Business Overview
11.9.3 Novetide Peptide Based Cardiovascular Therapeutics Introduction
11.9.4 Novetide Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.9.5 Novetide Recent Development
11.10 Amneal Pharmaceuticals
11.10.1 Amneal Pharmaceuticals Company Details
11.10.2 Amneal Pharmaceuticals Business Overview
11.10.3 Amneal Pharmaceuticals Peptide Based Cardiovascular Therapeutics Introduction
11.10.4 Amneal Pharmaceuticals Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.10.5 Amneal Pharmaceuticals Recent Development
11.11 Dr. Reddy’s Laboratories
11.11.1 Dr. Reddy’s Laboratories Company Details
11.11.2 Dr. Reddy’s Laboratories Business Overview
11.11.3 Dr. Reddy’s Laboratories Peptide Based Cardiovascular Therapeutics Introduction
11.11.4 Dr. Reddy’s Laboratories Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
11.11.5 Dr. Reddy’s Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Peptide Based Cardiovascular Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bivalirudin
Table 3. Key Players of Eptifibatide
Table 4. Key Players of Others
Table 5. Global Peptide Based Cardiovascular Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peptide Based Cardiovascular Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide Based Cardiovascular Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peptide Based Cardiovascular Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peptide Based Cardiovascular Therapeutics Market Share by Regions (2022-2027)
Table 11. Peptide Based Cardiovascular Therapeutics Market Trends
Table 12. Peptide Based Cardiovascular Therapeutics Market Drivers
Table 13. Peptide Based Cardiovascular Therapeutics Market Challenges
Table 14. Peptide Based Cardiovascular Therapeutics Market Restraints
Table 15. Global Peptide Based Cardiovascular Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peptide Based Cardiovascular Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Peptide Based Cardiovascular Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cardiovascular Therapeutics as of 2020)
Table 18. Ranking of Global Top Peptide Based Cardiovascular Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peptide Based Cardiovascular Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Based Cardiovascular Therapeutics Product Solution and Service
Table 22. Date of Enter into Peptide Based Cardiovascular Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peptide Based Cardiovascular Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Peptide Based Cardiovascular Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Peptide Based Cardiovascular Therapeutics Product
Table 65. Pfizer Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Peptide Based Cardiovascular Therapeutics Product
Table 70. AstraZeneca Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Peptide Based Cardiovascular Therapeutics Product
Table 75. Novartis Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Ipsen Company Details
Table 78. Ipsen Business Overview
Table 79. Ipsen Peptide Based Cardiovascular Therapeutics Product
Table 80. Ipsen Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Ipsen Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Peptide Based Cardiovascular Therapeutics Product
Table 85. Merck Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Peptide Based Cardiovascular Therapeutics Product
Table 90. Mylan Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Fresenius Company Details
Table 93. Fresenius Business Overview
Table 94. Fresenius Peptide Based Cardiovascular Therapeutics Product
Table 95. Fresenius Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Fresenius Recent Development
Table 97. Apotex Holdings Company Details
Table 98. Apotex Holdings Business Overview
Table 99. Apotex Holdings Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Apotex Holdings Recent Development
Table 101. Novetide Company Details
Table 102. Novetide Business Overview
Table 103. Novetide Peptide Based Cardiovascular Therapeutics Product
Table 104. Novetide Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Novetide Recent Development
Table 106. Amneal Pharmaceuticals Company Details
Table 107. Amneal Pharmaceuticals Business Overview
Table 108. Amneal Pharmaceuticals Peptide Based Cardiovascular Therapeutics Product
Table 109. Amneal Pharmaceuticals Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Amneal Pharmaceuticals Recent Development
Table 111. Dr. Reddy's Laboratories Company Details
Table 112. Dr. Reddy's Laboratories Business Overview
Table 113. Dr. Reddy's Laboratories Peptide Based Cardiovascular Therapeutics Product
Table 114. Dr. Reddy's Laboratories Revenue in Peptide Based Cardiovascular Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Dr. Reddy's Laboratories Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Cardiovascular Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Bivalirudin Features
Figure 3. Eptifibatide Features
Figure 4. Others Features
Figure 5. Global Peptide Based Cardiovascular Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Peptide Based Cardiovascular Therapeutics Report Years Considered
Figure 10. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Peptide Based Cardiovascular Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Peptide Based Cardiovascular Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Peptide Based Cardiovascular Therapeutics Market Share by Players in 2020
Figure 15. Global Top Peptide Based Cardiovascular Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cardiovascular Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Peptide Based Cardiovascular Therapeutics Revenue in 2020
Figure 17. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Peptide Based Cardiovascular Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Peptide Based Cardiovascular Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Peptide Based Cardiovascular Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Peptide Based Cardiovascular Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide Based Cardiovascular Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Peptide Based Cardiovascular Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Peptide Based Cardiovascular Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Peptide Based Cardiovascular Therapeutics Market Share by Region (2016-2027)
Figure 39. China Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide Based Cardiovascular Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Peptide Based Cardiovascular Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Peptide Based Cardiovascular Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Peptide Based Cardiovascular Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Peptide Based Cardiovascular Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 61. Ipsen Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 64. Fresenius Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 65. Apotex Holdings Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 66. Novetide Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 67. Amneal Pharmaceuticals Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Peptide Based Cardiovascular Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース癌治療薬市場規模・現状・予測（2021年-2027年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…
- 世界のペプチドベース代謝障害治療薬市場規模・現状・予測（2021年-2027年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…